Cargando…

SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review

The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a v...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathizadeh, Hadis, Afshar, Saman, Masoudi, Mahmood Reza, Gholizadeh, Pourya, Asgharzadeh, Mohammad, Ganbarov, Khudaverdi, Köse, Şükran, Yousefi, Mehdi, Kafil, Hossein Samadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364403/
https://www.ncbi.nlm.nih.gov/pubmed/34403674
http://dx.doi.org/10.1016/j.ijbiomac.2021.08.076
_version_ 1783738526405230592
author Fathizadeh, Hadis
Afshar, Saman
Masoudi, Mahmood Reza
Gholizadeh, Pourya
Asgharzadeh, Mohammad
Ganbarov, Khudaverdi
Köse, Şükran
Yousefi, Mehdi
Kafil, Hossein Samadi
author_facet Fathizadeh, Hadis
Afshar, Saman
Masoudi, Mahmood Reza
Gholizadeh, Pourya
Asgharzadeh, Mohammad
Ganbarov, Khudaverdi
Köse, Şükran
Yousefi, Mehdi
Kafil, Hossein Samadi
author_sort Fathizadeh, Hadis
collection PubMed
description The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines.
format Online
Article
Text
id pubmed-8364403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-83644032021-08-15 SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review Fathizadeh, Hadis Afshar, Saman Masoudi, Mahmood Reza Gholizadeh, Pourya Asgharzadeh, Mohammad Ganbarov, Khudaverdi Köse, Şükran Yousefi, Mehdi Kafil, Hossein Samadi Int J Biol Macromol Review The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines. Elsevier B.V. 2021-10-01 2021-08-14 /pmc/articles/PMC8364403/ /pubmed/34403674 http://dx.doi.org/10.1016/j.ijbiomac.2021.08.076 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Fathizadeh, Hadis
Afshar, Saman
Masoudi, Mahmood Reza
Gholizadeh, Pourya
Asgharzadeh, Mohammad
Ganbarov, Khudaverdi
Köse, Şükran
Yousefi, Mehdi
Kafil, Hossein Samadi
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
title SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
title_full SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
title_fullStr SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
title_full_unstemmed SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
title_short SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
title_sort sars-cov-2 (covid-19) vaccines structure, mechanisms and effectiveness: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364403/
https://www.ncbi.nlm.nih.gov/pubmed/34403674
http://dx.doi.org/10.1016/j.ijbiomac.2021.08.076
work_keys_str_mv AT fathizadehhadis sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT afsharsaman sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT masoudimahmoodreza sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT gholizadehpourya sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT asgharzadehmohammad sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT ganbarovkhudaverdi sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT kosesukran sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT yousefimehdi sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview
AT kafilhosseinsamadi sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview